Orca Investment Management LLC Makes New $3.60 Million Investment in CVS Health Corporation $CVS

Orca Investment Management LLC acquired a new position in shares of CVS Health Corporation (NYSE:CVS) during the second quarter, Holdings Channel reports. The institutional investor acquired 34,836 shares of the pharmacy operator’s stock, valued at approximately $3,604,000. CVS Health comprises 2.6% of Orca Investment Management LLC’s portfolio, making the stock its 10th largest position.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of CVS. Beaird Harris Wealth Management LLC raised its position in CVS Health by 201.0% in the 2nd quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator’s stock valued at $30,000 after purchasing an additional 195 shares in the last quarter. Swiss RE Ltd. purchased a new position in shares of CVS Health in the 4th quarter valued at about $26,000. Caitong International Asset Management Co. Ltd grew its position in shares of CVS Health by 407.2% during the third quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock worth $26,000 after buying an additional 281 shares in the last quarter. Sankala Group LLC purchased a new stake in shares of CVS Health during the fourth quarter worth approximately $28,000. Finally, Mcguire Capital Advisors Inc. purchased a new stake in shares of CVS Health during the fourth quarter worth approximately $28,000. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research analysts recently issued reports on the stock. Wells Fargo & Company lifted their price target on shares of CVS Health from $103.00 to $123.00 and gave the stock an “overweight” rating in a research note on Monday, July 13th. Bank of America increased their price objective on shares of CVS Health from $100.00 to $110.00 and gave the company a “buy” rating in a research report on Monday, June 22nd. Weiss Ratings upgraded shares of CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, August 5th. DA Davidson lifted their price objective on shares of CVS Health from $80.00 to $100.00 and gave the stock a “buy” rating in a research report on Thursday, May 7th. Finally, Argus boosted their target price on shares of CVS Health from $90.00 to $104.00 and gave the stock a “buy” rating in a research note on Thursday, May 14th. Twenty-two equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $106.75.

CVS Health Stock Performance

Shares of CVS opened at $97.09 on Friday. The company has a market capitalization of $124.18 billion, a price-to-earnings ratio of 25.69, a price-to-earnings-growth ratio of 0.93 and a beta of 0.61. CVS Health Corporation has a 52-week low of $67.42 and a 52-week high of $110.68. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74. The stock has a 50 day moving average price of $102.52 and a 200 day moving average price of $88.23.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, topping the consensus estimate of $1.87 by $0.71. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The business had revenue of $106.10 billion during the quarter, compared to the consensus estimate of $100.03 billion. During the same quarter in the previous year, the firm earned $1.81 EPS. The company’s revenue was up 7.3% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Research analysts predict that CVS Health Corporation will post 8.02 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd were paid a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 2.7%. The ex-dividend date was Thursday, July 23rd. CVS Health’s dividend payout ratio is currently 70.37%.

Insider Activity

In other news, Director Larry Robbins sold 1,983,538 shares of CVS Health stock in a transaction dated Tuesday, May 19th. The stock was sold at an average price of $94.45, for a total transaction of $187,345,164.10. Following the sale, the director owned 6,213,261 shares in the company, valued at approximately $586,842,501.45. The trade was a 24.20% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders sold a total of 3,372,000 shares of company stock worth $317,473,598 over the last 90 days. Company insiders own 0.85% of the company’s stock.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.